Left ventricular myocardial work improves in response to treatment and is associated with survival among patients with light chain cardiac amyloidosis
European Heart Journal - Cardiovascular Imaging · 30.04.2024 · 25 (5) · 698-707
DOI: 10.1093/ehjci/jead351 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Heart Journal - Cardiovascular Imaging, online erschienen am 24.12.2023. Verfasst von Alexandros Briasoulis und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Therapeutics, Faculty of Medicine, National and Kapodistrian University of Athens, Vassilisis Sofias 80, Athens 11528, Greece. Hauptthemen laut MEDLINE: Echocardiography. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
Aims
Complete haematologic response to treatment for light chain cardiac amyloidosis (AL-CA) may lead to improvement of myocardial function and better outcomes. We sought to evaluate the effect of response to treatment for AL-CA on echocardiographic indices of myocardial deformation and work and their prognostic significance. Methods and results Sixty-one patients treated for AL were enrolled and underwent echocardiographic assessment at baseline and at 1 year. Patients were stratified according to haematologic response as complete or not complete responders. A significant reduction in median N-terminal pro-brain natriuretic peptide (NT-proBNP) (2771–1486 pg/mL; P < 0.001) and posterior wall thickness (13–12 mm; P = 0.002) and an increase in global work index (GWI) (1115–1356 mmHg%; P = 0.018) was observed at 1 year. Patients with complete response (CR) had a more pronounced decrease in intraventricular septum thickness (14.2–12.0 mm; P = 0.006), improved global longitudinal strain (GLS) (−11.6 to −13.1%; P for interaction = 0.045), increased global constructive work (1245–1436 mmHg%; P = 0.008), and GWI (926–1250 mmHg%, P = 0.002) compared with non-CR. Furthermore, deltaGLS (ρspearman = 0.35; P < 0.001) and deltaGWI (ρspearman = −0.32; P = 0.02) correlated with delta NT-proBNP. Importantly, patients with GLS and GWI response had a better prognosis (log-rank P = 0.048 and log-rank P = 0.007, respectively). After adjustment for Mayo stage, gender, and response status, deltaGLS [hazard ratio (HR) = 1.404, P = 0.046 per 1% increase] and deltaGWI (HR = 0.996, P = 0.042 per 1mmHg% increase) were independent predictors of survival.
Conclusion
Complete haematologic response to treatment is associated with improved left ventricular myocardial work indices, and their change is associated with improved survival in AL-CA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Therapeutics, Faculty of Medicine, National and Kapodistrian University of Athens, Vassilisis Sofias 80, Athens 11528, Greece.
ORCID-Profile: Alexandros Briasoulis, Kimon Stamatelopoulos
Zitieren
APA
Briasoulis, A., Bampatsias, D., Petropoulos, I., Rempakos, A., Patras, R., Theodorakakou, F., Makris, N., Dimopoulos, M. A., Stamatelopoulos, K., & Kastritis, E. (2024). Left ventricular myocardial work improves in response to treatment and is associated with survival among patients with light chain cardiac amyloidosis. European Heart Journal - Cardiovascular Imaging, 25(5), 698-707. https://doi.org/10.1093/ehjci/jead351
Vancouver
Briasoulis A, Bampatsias D, Petropoulos I, Rempakos A, Patras R, Theodorakakou F, et al. Left ventricular myocardial work improves in response to treatment and is associated with survival among patients with light chain cardiac amyloidosis. European Heart Journal - Cardiovascular Imaging. 2024;25(5):698-707. doi:10.1093/ehjci/jead351
BibTeX
@article{Briasoulis2024,
author = {Briasoulis, Alexandros and Bampatsias, Dimitrios and Petropoulos, Ioannis and Rempakos, Athanasios and Patras, Raphael and Theodorakakou, Foteini and Makris, Nikolaos and Dimopoulos, Meletios Athanasios and Stamatelopoulos, Kimon and Kastritis, Efstathios},
title = {Left ventricular myocardial work improves in response to treatment and is associated with survival among patients with light chain cardiac amyloidosis},
journal = {European Heart Journal - Cardiovascular Imaging},
year = {2024},
volume = {25},
number = {5},
pages = {698--707},
doi = {10.1093/ehjci/jead351}
}
EUVIMED